EC Number   |
Inhibitors |
Structure |
|---|
   3.4.21.96 | 3,4-dichloroisocoumarin |
complete and irreversible inhibition with 0.1 mM |
   |
| 3.4.21.96 | alpha-casein |
maximum activity is observed in a basal minimal defined medium, whereas in the presence of alpha-casein CEP activity is inhibited 1fold |
|
| 3.4.21.96 | Ba2+ |
1 mM, 82% of initial activity |
|
| 3.4.21.96 | beta-casein |
maximum activity is observed in a basal minimal defined medium, whereas in the presence of beta-casein CEP activity is inhibited 1.2fold |
|
| 3.4.21.96 | branched-chain amino acids |
maximum activity is observed in a basal minimal defined medium, whereas in the presence of branched-chain amino acids CEP activity is inhibited 1.7fold |
|
| 3.4.21.96 | casamino acid |
maximum activity is observed in a basal minimal defined medium, whereas in the presence of casamino acid 1% (w,v) or 0.2% (w,v) CEP activity is inhibited 70fold or 20fold, respectively |
|
| 3.4.21.96 | casitone |
maximum activity is observed in a basal minimal defined medium, whereas in the presence of casitone 1% (w,v) or 2% (w,v) CEP activity is inhibited 99fold or 51fold, respectively |
|
| 3.4.21.96 | Cu2+ |
1 mM, 77% of initial activity |
|
| 3.4.21.96 | EDTA |
1 mM, 45% of initial activity |
|
| 3.4.21.96 | EGTA |
1 mM, 52% of initial activity |
|
